SCHEMBL4740070

SCHEMBL4740070

NC(=O)N(c1ccc(-c2cccc3[nH]nc(N)c23)cc1)c1cccc(Br)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 14/20 0.62
KIT P10721 10/20 0.60
FLT3 P36888 10/20 0.60
LCK P06239 5/20 0.59
CSF1R P07333 5/20 0.59
FGFR1 P11362 4/20 0.59
PRKACA P17612 4/20 0.59
ROCK1 Q13464 4/20 0.59
PLK4 O00444 3/20 0.59
AURKA O14965 3/20 0.59
LYN P07948 3/20 0.59
SRC P12931 3/20 0.59
RPS6KB1 P23443 3/20 0.59
MARK3 P27448 3/20 0.59
BLK P51451 3/20 0.59
MARK2 Q7KZI7 3/20 0.59
AURKB Q96GD4 3/20 0.59
SGK2 Q9HBY8 3/20 0.59
JAK2 O60674 2/20 0.59
CDK1 P06493 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27657352 0.89 KDR (0.66) KDRKITFLT3LCKCSF1R
SCHEMBL4739859 0.88 KDR (0.63) KDRKITFLT3LCKCSF1R
SCHEMBL3363647 0.87 KDR (0.68) KDRKITFLT3LCKCSF1R
SCHEMBL4739562 0.87 KDR (0.74) KDRKITFLT3LCKCSF1R
SCHEMBL27657299 0.87 KDR (0.65) KDRKITFLT3LCKCSF1R
SCHEMBL27636494 0.87 KDR (0.49) KDRKITFLT3LCKCSF1R
SCHEMBL27657350 0.86 KDR (0.56) KDRKITFLT3LCKCSF1R
SCHEMBL27636462 0.85 KDR (0.60) KDRKITFLT3LCKCSF1R
SCHEMBL27657358 0.85 KDR (0.58) KDRKITFLT3LCKCSF1R
SCHEMBL27657326 0.85 KDR (0.70) KDRKITFLT3LCKCSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1826324-B indazole, Benzisoxazole and benzisothiazole kinase inhibitors ABBOTT LABORATORIES (US) 2011-12-07 CN claimed
WO-2008080110-A1 METHODS FOR TREATING MACULAR EDEMA AND PATHOLOGIC OCULAR ANGIOGENESIS USING A NEUROPROTECTIVE AGENT AND A RECEPTOR TYROSINE KINASE INHIBITOR ALCON, INC. (CH) 2008-07-03 WO claimed
CN-1826324-A Indazole, benzisoxazole and benzisothiazole kinase inhibitors ABBOTT LAB (US) 2006-08-30 CN claimed
CN-102417487-A Indazole, benzisoxazole and benzisothiazole kinase inhibitors ABBOTT LAB 2012-04-18 CN disclosed
CN-1826324-B indazole, Benzisoxazole and benzisothiazole kinase inhibitors ABBOTT LABORATORIES (US) 2011-12-07 CN disclosed
CN-101827584-A Solid dispersion product of N-aryl ureido drugs ABBOTT GMBH & CO KG 2010-09-08 CN disclosed
CN-1826324-A Indazole, benzisoxazole and benzisothiazole kinase inhibitors ABBOTT LAB (US) 2006-08-30 CN disclosed